- General population
- Infants (<1 year)
- Hospital
- Respiratory syncytial virus
- Respiratory syncytial virus infection
- Pharmacological intervention
- Monoclonal antibodies
- Nirsevimab
Setting: Hospital
Encompassing all units and departments within a hospital setting
- Adults (18-64 years)
- People at high risk of STIs
- Men who have sex with men
- PrEP users
- Hospital
- Chlamydia trachomatis
- Neisseria gonorrhoeae
- Treponema pallidum
- HIV
- Hepatitis B
- Hepatitis C
- Sexually transmitted infection
- Syphilis
- Chlamydia
- Gonorrhea
- HIV
- Adults (18-64 years)
- General population
- People at high risk of STIs
- Men who have sex with men
- Hospital
- Infectious diseases unit
- Monkeypox virus
- Mpox
- Sexually transmitted infection
- Blood sample
- Serum sample
- Adults (18-64 years)
- General population
- Hospital
- SARS-CoV-2
- Acute COVID-19
- Blood sample
- PBMC
- Whole blood
- Pregnant women
- Hospital
- Arbovirus
- Dengue virus
- Vector-borne disease
- Arboviral disease
- Vector-borne disease
- Adults (18-64 years)
- Elderly (≥65 years)
- Adolescents (12-17 years)
- Children (1-11 years)
- Hospital
- Neisseria gonorrhoeae
- Sexually transmitted infection
- Adults (18-64 years)
- General population
- Pregnant women
- Hospital
- Outpatient clinic
- Chlamydia trachomatis
- Neisseria gonorrhoeae
- Sexually transmitted infection
- Adults (18-64 years)
- General population
- Hospital
- Chlamydia trachomatis
- Neisseria gonorrhoeae
- Mycoplasma genitalium
- Trichomonas vaginalis
- Sexually transmitted infection
- Non pharmacological intervention
- RT-PCR
- Adults (18-64 years)
- Elderly (≥65 years)
- People at high risk of STIs
- PrEP users
- Hospital
- Community
- Primary care
- Chlamydia trachomatis
- Neisseria gonorrhoeae
- Treponema pallidum
- Sexually transmitted infection
- Syphilis
- Pharmacological intervention
- PrEP-bSTI
- Adults (18-64 years)
- Elderly (≥65 years)
- Travelers
- Hospital
- Emergency department
- Arbovirus
- Chikungunya virus
- Vector-borne
- Dengue virus
- Zika virus
- Arboviral disease
- Vector-borne disease
- Adults (18-64 years)
- Elderly (≥65 years)
- Infants (<1 year)
- Adolescents (12-17 years)
- Children (1-11 years)
- Hospital
- Outpatient clinic
- Emergency department
- Arbovirus
- Chikungunya virus
- Vector-borne
- Dengue virus
- Zika virus
- West Nile virus
- Japanese encephalitis virus
- Arboviral disease
- Vector-borne disease
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- Outpatient clinic
- Telemedicine
- SARS-CoV-2
- Post COVID-19 condition
- Non pharmacological intervention
- Rehabilitation
- Breathing therapy